Drug-resistant tuberculosis is one of the world’s most urgent public health challenges, and tackling it takes more than ambition. It takes faster answers, better data and tools that help experts see what they’re up against.
That's why Illumina came to Explanimate with a complex story to tell: how Next Generation Sequencing, or NGS, can support the fight against drug-resistant tuberculosis.
The audience included TB researchers, clinicians, policymakers, program managers, advocates, funders and media, so the animation needed to be scientifically credible without becoming a three-minute scientific report in a lab coat. The goal was to explain “Why NGS for Drug Resistant TB?” and support World TB Day as an educational resource.
The story started with a bold ambition: helping end the global TB epidemic by 2030.
From there, the script introduced the challenge: TB bacteria can mutate and adapt to anti-TB drugs, making resistant strains harder and more expensive to treat. Current testing methods can also have limitations, from slow culture-based testing to molecular tests that only check resistance to a limited number of drugs.
Our job was to turn that scientific complexity into a clear, hopeful story about better information leading to better decisions.
From there, the idea was to build a narrative that felt natural and human. Something that flowed like a glimpse into real life.
We leaned into warm, relatable moments and a gentle sense of progression, letting the visuals do the heavy lifting rather than forcing it all through voiceover.
The animation shows how NGS can help reveal the full picture of drug-resistant TB, from individual treatment planning to population-level surveillance. The script explains both targeted sequencing and whole genome sequencing, showing how they can help detect resistance, link cases, trace transmission pathways and monitor new mutations as they arise.
Not bad for something that starts with a sputum sample.
The visual style needed to feel educational, hopeful and lasting. So instead of burying the audience in technical detail, the animation used researchers, clinicians, patients, reports, maps and genome visuals to guide the story.
The science stayed accurate. The message stayed human.
With a topic this technical, refinement was all about balance: keep the science accurate and keep the story moving.
The script went through careful review to make sure the explanation of drug-resistant TB, targeted sequencing and whole genome sequencing stayed clear without flattening the science. Each section was shaped to build logically from the global challenge, to the testing gap, to the role NGS can play in helping researchers and public health teams see the bigger picture.
The final polish focused on clarity, pacing and confidence. Enough detail for a specialist audience. Enough simplicity for everyone else.
The final hero animation was created as a World TB Day educational asset, supported by an animated booklet and social tiles.
The result gave Illumina a clear, campaign-ready way to explain the role of NGS in the fight against drug-resistant TB, turning a complex health technology into a message people could understand, share and remember.
Because when the science is this important, clarity is not decoration. It is the point.
